Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Bone Density × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 34 Neoplasms 7 Neoplasm Metastasis 2 Sarcoma 1 Quality of Life 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Subjects 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Bone Density 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Tamoxifen 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00784940 2009-04-27

ATAC - Bone Density Sub-Protocol

AstraZeneca

Phase 3 Completed

Bone Density

Data powered by HemOnc (CC BY 4.0) Colophon ⚡